Immuneering Corp (IMRX)
1.64
+0.08
(+5.13%)
USD |
NASDAQ |
May 03, 16:00
1.64
0.00 (0.00%)
After-Hours: 20:00
Immuneering Market Cap: 48.63M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 48.63M |
| May 02, 2024 | 46.26M |
| May 01, 2024 | 45.37M |
| April 30, 2024 | 42.11M |
| April 29, 2024 | 43.89M |
| April 26, 2024 | 43.59M |
| April 25, 2024 | 42.40M |
| April 24, 2024 | 44.48M |
| April 23, 2024 | 48.34M |
| April 22, 2024 | 51.00M |
| April 19, 2024 | 53.38M |
| April 18, 2024 | 52.49M |
| April 17, 2024 | 54.47M |
| April 16, 2024 | 53.88M |
| April 15, 2024 | 56.08M |
| April 12, 2024 | 61.49M |
| April 11, 2024 | 60.91M |
| April 10, 2024 | 58.86M |
| April 09, 2024 | 64.13M |
| April 08, 2024 | 62.08M |
| April 05, 2024 | 64.13M |
| April 04, 2024 | 68.82M |
| April 03, 2024 | 70.28M |
| April 02, 2024 | 73.21M |
| April 01, 2024 | 80.53M |
| Date | Value |
|---|---|
| March 28, 2024 | 84.63M |
| March 27, 2024 | 71.16M |
| March 26, 2024 | 69.99M |
| March 25, 2024 | 74.09M |
| March 22, 2024 | 74.67M |
| March 21, 2024 | 79.94M |
| March 20, 2024 | 81.41M |
| March 19, 2024 | 75.26M |
| March 18, 2024 | 74.97M |
| March 15, 2024 | 55.93M |
| March 14, 2024 | 84.92M |
| March 13, 2024 | 172.19M |
| March 12, 2024 | 171.45M |
| March 11, 2024 | 173.80M |
| March 08, 2024 | 192.10M |
| March 07, 2024 | 195.61M |
| March 06, 2024 | 187.41M |
| March 05, 2024 | 181.56M |
| March 04, 2024 | 180.09M |
| March 01, 2024 | 180.09M |
| February 29, 2024 | 181.56M |
| February 28, 2024 | 185.95M |
| February 27, 2024 | 188.29M |
| February 26, 2024 | 187.12M |
| February 23, 2024 | 189.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.11M
Minimum
Apr 30 2024
851.81M
Maximum
Sep 27 2021
273.88M
Average
208.40M
Median
Oct 04 2023
Market Cap Benchmarks
| Geron Corp | 2.331B |
| SELLAS Life Sciences Group Inc | 74.84M |
| Elicio Therapeutics Inc | 91.78M |
| Vistagen Therapeutics Inc | 121.61M |
| ADMA Biologics Inc | 1.554B |
Market Cap Related Metrics
| PS Ratio | 147.00 |
| PEG Ratio | -0.0614 |
| Price to Book Value | 0.5369 |
| Price | 1.64 |
| Earnings Yield | -115.2% |
| PEGY Ratio | -0.0614 |